Redhill Biopharma Ltd banner

Redhill Biopharma Ltd
NASDAQ:RDHL

Watchlist Manager
Redhill Biopharma Ltd Logo
Redhill Biopharma Ltd
NASDAQ:RDHL
Watchlist
Price: 0.921 USD 4.66% Market Closed
Market Cap: $4.8m

Wall St Price Targets

RDHL Price Targets Summary
Redhill Biopharma Ltd

There are no price targets for RDHL.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
Redhill Biopharma Ltd Competitors:
Price Targets

Revenue
Forecast

84% / Year
Past Growth
382% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss
84% / Year
Past Growth
382% / Year
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Over the last 11 years, the compound annual growth rate for Revenue has been 84%. The projected CAGR for the next 1 year is 382%.

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Gross Profit Forecast
is not available for Redhill Biopharma Ltd

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Pre-Tax Income Forecast
is not available for Redhill Biopharma Ltd

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-100%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-100%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is RDHL's stock price target?
Not Available

RDHL does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for Redhill Biopharma Ltd?
Projected CAGR
382%

Over the last 11 years, the compound annual growth rate for Revenue has been 84%. The projected CAGR for the next 1 year is 382%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett